(Reuters) – German group Siemens Healthineers AG (SHLG.DE) is in advanced talks to purchase Varian Medical Systems Inc (VAR.N), a maker of devices and software for treating cancer, in a deal that will value the medical device maker at about $15 billion, Bloomberg News reported late on Saturday.

The deal could be announced in the coming days, the report added, citing sources.

The talks could still fall apart, according to Bloomberg.

Both companies did not immediately respond to a request for comment.

Varian, based in Palo Alto, California, is focused on developing and delivering innovative cancer treatments and has 10,000 employees. In 2019, it reported total revenue of $3.2 billion.

Siemens Healthineers, a spinoff from Siemens AG (SIEGn.DE) in 2018, makes X-ray, ultrasound and MRI equipment.

Reporting by Kanishka Singh in Bengaluru; Editing by Cynthia Osterman

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Large U.S. banks to take small business loan applications next week: Mnuchin

WASHINGTON (Reuters) – U.S. Treasury Secretary Steven Mnuchin said on Friday he expects all large U.S. banks to be participating in a newly launched, $350 billion small business coronavirus rescue loan program by next week, with community banks issuing most…

Goldman Sachs sees 1% drop in global GDP due to ‘coronacrisis’

LONDON (Reuters) – Goldman Sachs said it expected global real gross domestic product to contract by about 1% in 2020, a sharper economic decline than in the year following the 2008 global financial crisis. Global governments have been taking unprecedented…

Nestle teams up with Canadian plant-based ingredients makers

ZURICH (Reuters) – Food group Nestle (NESN.S) has teamed up with Canadian plant-based food ingredient makers Burcon (BU.TO) and Merit to speed up innovation in the fast-growing business segment, it said on Friday. The collaboration will allow Nestle, which launched…

China’s progress on economic resumption

BEIJING — China is steadily reviving its economy as the country has kept COVID-19 under control. The following facts and figures indicate how the country is forging ahead in the resumption of work and production: — China’s civil aviation regulator…